Cinacalcet Hydrochloride and Gemzar

• Generic Name: cinacalcet
• Dosage Forms: n.a.
• Other Brand Names: Sensipar

Treatment of secondary hyperparathyroidism associated with chronic renal disease in patients who are undergoing hemodialysis or peritoneal dialysis.

Safety and efficacy in patients who are not undergoing dialysis have not been established.

May be used alone or in conjunction with vitamin D analogs and/or phosphate binders.

Effects on clinical outcomes remain to be fully determined. The primary finding of the EVOLVE trial (a lack of effect on mortality or major cardiovascular events ) is controversial because of study limitations.

Management of hypercalcemia associated with parathyroid carcinoma; designated an orphan drug by FDA for this use.

Treatment of hypercalcemia associated with primary hyperparathyroidism in patients who would be candidates for parathyroidectomy based on serum calcium concentrations but who are unable to undergo the surgery; designated an orphan drug by FDA for this use.

• Generic Name: gemcitabine
• Dosage Forms: injection, powder, lyophilized, for solution
• Other Brand Names: Gemzar, Infugem

Gemzar (gemcitabine) is a cancer medication that interferes with the growth and spread of cancer cells in the body.

Gemzar is used to treat cancers of the pancreas, lung, ovary, and breast.

Gemzar is sometimes given with other cancer medicines, or when other cancer treatments did not work or have stopped working.